5Lindenfeld J,Page RL 2nd,Zolty R,et al.Drug therapy in the heart transplant recipient:Part Ⅲ:common medical problems.Circulation,2005,111(1):113-117.
6Antretter H,Hofer D,Hangler H,et al.Is it possible to reduce CMV-infections after heart transplantation with a three-month antiviral prophylaxis? 7 years experience with ganciclovir.Wien Klin Wochenschr,2004,116(15-16):542-551.
7McNeil K,Foweraker J,Wreghitt T.Infectious complications of lung transplantation.In:Banner NR,Polak JM,Yacoub MH.Lung Transplantation.Cambridge,UK:Cambridge University Press,2003.250-260.
8Kotloff RM,Ahya VN.Medical complications of lung transplantation.Eur Respir J,2004,23 (2):334-342.
9Wieland T,Liebold A,Jagiello M,et al.Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.J Heart Lung Transplant,2005,24(1):102-104.
10Fishman JA,Rubin RH.Infection in organ-transplant recipients.N Engl J Med,1998,338(24):1741-1751.
